You cannot afford to miss World CB & CDx 2022, as key industry stakeholders gather and leave no stone unturned to advance more life changing precision and targeted drugs to patients. Returning in-person for the first time in three years, hear the latest insights, case studies and technologies enhancing your predictive biomarker discovery, to support next generation CDx development, informed clinical decisions, regulatory approval & a robust go-to market strategy for a breakthrough therapy.Īcross 2-days & 3 distinct tracks, this is your only end-to-end biomarker-driven & diagnostic enabled drug development summit, led by 70+ industry leaders triumphing and overcoming challenges to predictive biomarker development and commercialization. 2016 Lasker Award for Basic Medical Research Professor at Johns Hopkins University School of. Dates, Location, Program, Handouts, and CME hours Annual Spring Conference Conference on Medical Student Education Conference on Practice and Quality. Spurred on by a number of recent exciting biomarker-driven therapy and CDx approvals by the FDA, including Eli Lilly’s Verzenio, J&J’s Amivantamab & Takeda’s Mobocertinib, the race to market is becoming ever fiercer to deliver the next-generation of safer & more effective therapies for defined patient populations.

The 12 th World Clinical Biomarkers & CDx Summit returns at a crucial time for the entire precision & targeted drug development industry.

Medical conferences 2016 boston